Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic...
Main Authors: | Katherine J. Wert, Gabriel Velez, Vijaya L. Kanchustambham, Vishnu Shankar, Lucy P. Evans, Jesse D. Sengillo, Richard N. Zare, Alexander G. Bassuk, Stephen H. Tsang, Vinit B. Mahajan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420300116 |
Similar Items
-
Proteomic analysis of elevated intraocular pressure with retinal detachment
by: Gabriel Velez, et al.
Published: (2017-04-01) -
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases
by: Christine L. Xu, et al.
Published: (2018-05-01) -
Phenotypic variance in Calpain-5 retinal degeneration
by: Peter H. Tang, et al.
Published: (2020-06-01) -
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
by: Jesse D. Sengillo, et al.
Published: (2017-01-01) -
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
by: Gabriel Velez, et al.
Published: (2021-02-01)